Mar

28

How to navigate the complex world of BIOSIMILARS

As the life sciences sector faces unprecedented challenges, the market for “generic” biopharmaceuticals is looking to be one of the few attractive targets. However, market entry poses significant challenges and will likely generate plenty of work for legal and regulatory ……more